Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $80,529 - $205,350
-134,216 Reduced 90.49%
14,100 $8,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $290 - $451
-277 Reduced 0.19%
148,316 $167,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $4,656 - $10,592
-3,880 Reduced 2.54%
148,593 $200,000
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $805 - $1,700
471 Added 0.31%
152,473 $283,000
Q3 2022

Nov 09, 2022

SELL
$1.9 - $8.63 $8,266 - $37,549
-4,351 Reduced 2.78%
152,002 $373,000
Q2 2022

Aug 12, 2022

SELL
$2.13 - $9.01 $21,681 - $91,712
-10,179 Reduced 6.11%
156,353 $381,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $4,320 - $10,725
688 Added 0.41%
166,532 $1.33 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $2.44 Million - $4.75 Million
165,844 New
165,844 $2.53 Million
Q3 2021

Feb 05, 2024

BUY
$24.31 - $33.6 $4.75 Million - $6.57 Million
195,462 Added 1386.26%
209,562 $5.96 Billion
Q2 2021

Jan 08, 2024

SELL
$26.09 - $40.4 $978,818 - $1.52 Million
-37,517 Reduced 17.79%
173,388 $5.85 Billion
Q1 2021

Jan 08, 2024

BUY
$33.06 - $56.93 $350,039 - $602,774
10,588 Added 5.29%
210,905 $8.06 Billion
Q4 2020

Jan 08, 2024

BUY
$39.09 - $57.4 $578,844 - $849,979
14,808 Added 7.98%
200,317 $8.38 Billion
Q3 2020

Jan 08, 2024

BUY
$28.43 - $44.67 $477,282 - $749,919
16,788 Added 9.95%
185,509 $8.04 Billion
Q2 2020

Jan 08, 2024

SELL
$11.71 - $30.29 $388,116 - $1 Million
-33,144 Reduced 16.42%
168,721 $5.11 Billion
Q1 2020

Jan 08, 2024

SELL
$7.64 - $27.5 $710,130 - $2.56 Million
-92,949 Reduced 31.53%
201,865 $2.76 Billion
Q4 2019

Jan 30, 2024

BUY
$15.02 - $20.57 $354,246 - $485,143
23,585 Added 8.7%
294,814 $4.76 Billion
Q4 2019

Jan 08, 2024

BUY
$15.02 - $20.57 $354,246 - $485,143
23,585 Added 8.7%
294,814 $4.76 Billion
Q3 2019

Jan 30, 2024

BUY
$18.85 - $27.5 $1.6 Million - $2.33 Million
84,739 Added 45.44%
271,229 $5.23 Billion
Q3 2019

Jan 08, 2024

BUY
$18.85 - $27.5 $4.4 Million - $6.42 Million
233,436 Added 617.67%
271,229 $5.23 Billion
Q2 2019

Jan 30, 2024

BUY
$17.37 - $26.27 $2.99 Million - $4.53 Million
172,390 Added 1222.62%
186,490 $4.38 Billion
Q2 2019

Jan 08, 2024

SELL
$17.37 - $26.27 $2.44 Million - $3.69 Million
-140,625 Reduced 78.82%
37,793 $4.39 Billion
Q1 2019

Jan 08, 2024

BUY
$10.65 - $25.75 $137,693 - $332,921
12,929 Added 7.81%
178,418 $4.18 Billion
Q4 2018

Jan 08, 2024

BUY
$9.26 - $16.38 $300,144 - $530,924
32,413 Added 24.36%
165,489 $1.83 Billion
Q3 2018

Jan 08, 2024

BUY
$7.54 - $18.31 $193,679 - $470,328
25,687 Added 23.92%
133,076 $2.23 Billion
Q2 2018

Jan 08, 2024

BUY
$4.87 - $8.42 $33,150 - $57,314
6,807 Added 6.77%
107,389 $789 Million
Q1 2018

Jan 08, 2024

BUY
$4.69 - $10.05 $193,279 - $414,170
41,211 Added 69.41%
100,582 $472 Million
Q4 2017

Jan 08, 2024

BUY
$7.86 - $9.99 $355,830 - $452,257
45,271
59,371 $539 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.